FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3099917933> ?p ?o ?g. }

• W3099917933 abstract "Rheumatoid arthritis (RA), an inflammatory joint disorder, independently increases the risk of cardiovascular disease (CVD). IL-1β contributes to both RA and CVD. We hypothesised that inhibiting IL-1 signalling with the IL-1R antagonist, anakinra, would dampen inflammation and promote resolution of atherosclerosis in arthritic mice.Low-density lipoprotein receptor (Ldlr)-deficient mice were fed a Western-type diet for 14 weeks to develop atherosclerotic plaques. Mice were then switched to a chow diet, promoting lesion regression, and randomised to a control group or into groups where arthritis was induced by passive transfer of K/BxN arthritogenic serum. The arthritic mice were further randomised to vehicle or anakinra.Arthritis impaired atherosclerotic lesion regression when cholesterol was lowered. This was associated with a higher burden of plaque macrophages, likely due to monocytosis, driven by myelopoiesis in the bone marrow and spleen. Interestingly, delayed intervention with anakinra had no effect on arthritis in these mice. However, a significant improvement in atherosclerotic plaque remodelling to a more stable phenotype was observed. This was associated with fewer circulating monocytes, caused by a reduction in splenic extramedullary myelopoiesis.We show that inhibiting IL-1 signalling in arthritic mice with pre-existing atherosclerosis promotes lesion remodelling to a more stable phenotype, that is less likely to rupture and cause ischemic events such as myocardial infarction. This suggests that IL-1R antagonism may suppress CVD complications in patients with RA. Furthermore, inhibiting IL-1β signalling in other patients with inflammatory diseases that also predispose to CVD may also benefit from anti-IL-1 therapy." @default.
• W3099917933 created "2020-11-23" @default.
• W3099917933 creator A5004778423 @default.
• W3099917933 creator A5013003637 @default.
• W3099917933 creator A5047139735 @default.
• W3099917933 creator A5057028052 @default.
• W3099917933 creator A5060070593 @default.
• W3099917933 creator A5062946947 @default.
• W3099917933 creator A5068619691 @default.
• W3099917933 creator A5068703844 @default.
• W3099917933 creator A5069608766 @default.
• W3099917933 creator A5075712626 @default.
• W3099917933 creator A5079876374 @default.
• W3099917933 creator A5087477908 @default.
• W3099917933 date "2020-01-01" @default.
• W3099917933 modified "2023-10-15" @default.
• W3099917933 title "Inhibition of interleukin‐1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis" @default.
• W3099917933 cites W126724734 @default.
• W3099917933 cites W1970845955 @default.
• W3099917933 cites W1972483153 @default.
• W3099917933 cites W2003331250 @default.
• W3099917933 cites W2011322417 @default.
• W3099917933 cites W2011437322 @default.
• W3099917933 cites W2032140498 @default.
• W3099917933 cites W2038772512 @default.
• W3099917933 cites W2041325252 @default.
• W3099917933 cites W2042227371 @default.
• W3099917933 cites W2050173346 @default.
• W3099917933 cites W2052554962 @default.
• W3099917933 cites W2106427090 @default.
• W3099917933 cites W2111935270 @default.
• W3099917933 cites W2117439999 @default.
• W3099917933 cites W2124558063 @default.
• W3099917933 cites W2126408248 @default.
• W3099917933 cites W2145249112 @default.
• W3099917933 cites W2145866317 @default.
• W3099917933 cites W2145899814 @default.
• W3099917933 cites W2158380859 @default.
• W3099917933 cites W2264175597 @default.
• W3099917933 cites W2343868815 @default.
• W3099917933 cites W2407393551 @default.
• W3099917933 cites W2597102949 @default.
• W3099917933 cites W2597865830 @default.
• W3099917933 cites W2613572458 @default.
• W3099917933 cites W2748400555 @default.
• W3099917933 cites W2792912137 @default.
• W3099917933 cites W2999775511 @default.
• W3099917933 doi "https://doi.org/10.1002/cti2.1206" @default.
• W3099917933 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7652637" @default.
• W3099917933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33204425" @default.
• W3099917933 hasPublicationYear "2020" @default.
• W3099917933 type Work @default.
• W3099917933 sameAs 3099917933 @default.
• W3099917933 citedByCount "9" @default.
• W3099917933 countsByYear W30999179332021 @default.
• W3099917933 countsByYear W30999179332022 @default.
• W3099917933 countsByYear W30999179332023 @default.
• W3099917933 crossrefType "journal-article" @default.
• W3099917933 hasAuthorship W3099917933A5004778423 @default.
• W3099917933 hasAuthorship W3099917933A5013003637 @default.
• W3099917933 hasAuthorship W3099917933A5047139735 @default.
• W3099917933 hasAuthorship W3099917933A5057028052 @default.
• W3099917933 hasAuthorship W3099917933A5060070593 @default.
• W3099917933 hasAuthorship W3099917933A5062946947 @default.
• W3099917933 hasAuthorship W3099917933A5068619691 @default.
• W3099917933 hasAuthorship W3099917933A5068703844 @default.
• W3099917933 hasAuthorship W3099917933A5069608766 @default.
• W3099917933 hasAuthorship W3099917933A5075712626 @default.
• W3099917933 hasAuthorship W3099917933A5079876374 @default.
• W3099917933 hasAuthorship W3099917933A5087477908 @default.
• W3099917933 hasBestOaLocation W30999179332 @default.
• W3099917933 hasConcept C126322002 @default.
• W3099917933 hasConcept C134018914 @default.
• W3099917933 hasConcept C142724271 @default.
• W3099917933 hasConcept C203014093 @default.
• W3099917933 hasConcept C2776914184 @default.
• W3099917933 hasConcept C2777077863 @default.
• W3099917933 hasConcept C2777575956 @default.
• W3099917933 hasConcept C2779134260 @default.
• W3099917933 hasConcept C2779244835 @default.
• W3099917933 hasConcept C2780007613 @default.
• W3099917933 hasConcept C2781087989 @default.
• W3099917933 hasConcept C2781156865 @default.
• W3099917933 hasConcept C2781228260 @default.
• W3099917933 hasConcept C71924100 @default.
• W3099917933 hasConceptScore W3099917933C126322002 @default.
• W3099917933 hasConceptScore W3099917933C134018914 @default.
• W3099917933 hasConceptScore W3099917933C142724271 @default.
• W3099917933 hasConceptScore W3099917933C203014093 @default.
• W3099917933 hasConceptScore W3099917933C2776914184 @default.
• W3099917933 hasConceptScore W3099917933C2777077863 @default.
• W3099917933 hasConceptScore W3099917933C2777575956 @default.
• W3099917933 hasConceptScore W3099917933C2779134260 @default.
• W3099917933 hasConceptScore W3099917933C2779244835 @default.
• W3099917933 hasConceptScore W3099917933C2780007613 @default.
• W3099917933 hasConceptScore W3099917933C2781087989 @default.
• W3099917933 hasConceptScore W3099917933C2781156865 @default.
• W3099917933 hasConceptScore W3099917933C2781228260 @default.
• W3099917933 hasConceptScore W3099917933C71924100 @default.
• W3099917933 hasFunder F4320310420 @default.

• next